Literature DB >> 101326

Cytotoxicity of human and baboon mononuclear phagocytes against schistosomula in vitro: induction by immune complexes containing IgE and Schistosoma mansoni antigens.

M Joseph, A Capron, A E Butterworth, R F Sturrock, V Houba.   

Abstract

Normal human blood monocytes, pre-incubated at 37 degrees C with sera from patients infected with Schistosoma mansoni, strongly adhered to S. mansoni schistosomula in vitro, whereas no significant adherence was induced by sera from uninfected individuals. Comparable adherence occurred with normal baboon blood monocytes or peritoneal macrophages when these cells were incubated with sera from S. mansoni-infected baboons. Adherence of macrophages to schistosomula was associated with damage to the larvae, as estimated by a 51Cr release technique. Neither adherence nor cytotoxicity was induced by pre-incubation of the schistosomula, instead of the monocytes, with immune serum. The relevant factor in immune serum was heat-labile, but was not a complement component. Absorption and ultracentrifugation experiments showed that immune complexes, containing S. mansoni-specific IgE antibody and soluble parasite antigens, produced monocyte or macrophage adherence and cytotoxicity. Similar observations have been reported previously in the rat model. Since the production of large amounts of IgE is a predominant feature of schistosome infections in man and experimental animals, it is possible that this new mode of mononuclear phagocyte activation could act as an immune effector mechanism against S. mansoni.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 101326      PMCID: PMC1537520     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Eosinophils as mediators of antibody-dependent damage to schistosomula.

Authors:  A E Butterworth; R F Sturrock; V Houba; A A Mahmoud; A Sher; P H Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Studies on schistosomiasis. 18. Some factors affecting resistance to Schistosoma mansoni infections in albino mice.

Authors:  G W HUNTER; R B CRANDALL; D E ZICKAFOOSE; Q B PURVIS
Journal:  Am J Trop Med Hyg       Date:  1962-01       Impact factor: 2.345

3.  Specific IgE antibodies in immune adherence of normal macrophages to Schistosoma mansoni schistosomules.

Authors:  A Capron; J P Dessaint; M Capron; H Bazin
Journal:  Nature       Date:  1975-02-06       Impact factor: 49.962

4.  Combined in vitro effects of rat antibody and neutrophilic leukocytes on schistosomula of Schistosoma mansoni.

Authors:  D A Dean; R Wistar; K D Murrell
Journal:  Am J Trop Med Hyg       Date:  1974-05       Impact factor: 2.345

5.  The effects of immune rhesus monkey serum on schistosomula of Schistosoma mansoni during cultivation in vitro.

Authors:  J A Clegg; S R Smithers
Journal:  Int J Parasitol       Date:  1972-03       Impact factor: 3.981

6.  Schistosoma mansoni infection in the rat. II. Effects of immunosuppression and serum and cell transfer on innate and acquired immunity.

Authors:  S E Maddison; S J Geiger; B Botero; I G Kagan
Journal:  J Parasitol       Date:  1970-12       Impact factor: 1.276

Review 7.  The immunology of schistosomiasis.

Authors:  S R Smithers; R J Terry
Journal:  Adv Parasitol       Date:  1969       Impact factor: 3.870

8.  Schistosoma mansoni in the baboon (Papio anubis): parasitological responses of Kenyan baboons to different exposures of a local parasite strain.

Authors:  R F Sturrock; A E Butterworth; V Houba
Journal:  Parasitology       Date:  1976-12       Impact factor: 3.234

9.  Naturally acquired resistance to experimental infections of Schistosoma mansoni in the rhesus monkey (Macaca mulatta).

Authors:  S R Smithers; R J Terry
Journal:  Parasitology       Date:  1965-11       Impact factor: 3.234

10.  A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum.

Authors:  A A Mahmoud; K S Warren; P A Peters
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Clinical significance of anti-IgE autoantibodies and immune complexes containing IgE.

Authors:  C G Magnusson; S G Johansson
Journal:  Clin Rev Allergy       Date:  1989

2.  IgG subclasses in human chronic schistosomiasis: over-production of schistosome-specific and non-specific IgG4.

Authors:  F N Boctor; J B Peter
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 3.  Fc epsilon receptor II-positive macrophages and platelets: potent effector cells in allergy and defence against helminth parasites.

Authors:  J P Dessaint; A Capron
Journal:  Springer Semin Immunopathol       Date:  1990

4.  Cells demonstrating Fc receptors for IgE.

Authors:  H Boltansky; M A Kaliner
Journal:  Surv Immunol Res       Date:  1984

5.  Destruction of the multicellular parasite Schistosoma mansoni by T lymphocytes.

Authors:  J J Ellner; G R Olds; C W Lee; M E Kleinhenz; K L Edmonds
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

Review 6.  Macrophages: progress and problems.

Authors:  D S Nelson
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

7.  The number and affinity of IgE receptors on dispersed human lung mast cells.

Authors:  J W Coleman; R C Godfrey
Journal:  Immunology       Date:  1981-12       Impact factor: 7.397

8.  Macrophage triggering by aggregated immunoglobulins. II. Comparison of IgE and IgG aggregates or immune complexes.

Authors:  J Pestel; J P Dessaint; M Joseph; H Bazin; A Capron
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  IgE antibody-mediated cytotoxicity of rat macrophages against microfilaria of Dipetalonema citeae in vitro.

Authors:  A Haque; M Joseph; M A Ouaissi; M Capron; A Capron
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

10.  Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E.

Authors:  M Joseph; A B Tonnel; A Capron; C Voisin
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.